ArticleJACC. Case reports2026
Focal Myocardial Fibrosis Mimicking Hypertrophy in INOCA and the Energetic Cost of Supranormal Ejection Fraction.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary vasospasm is a major cause of ischemia with nonobstructive coronary arteries; however, its long-term structural and energetic consequences on the myocardium remain under-recognized. CASE SUMMARY: A 72-year-old postmenopausal woman presented with chest discomfort and electrocardiographic findings suggestive of myocardial ischemia. Acetylcholine provocation testing revealed epicardial and microvascular coronary spasm. Cardiac magnetic resonance revealed focal late gadolinium enhancement in the interventricular septum, confirming replacement fibrosis mimicking hypertrophy. Additionally, the patient showed a supranormal ejection fraction of 79% and a markedly reduced end-systolic volume, indicating a hyperdynamic small left ventricle. DISCUSSION: This case demonstrates that recurrent coronary spasm is not benign and can be related to irreversible myocardial fibrosis and maladaptive hyperdynamic remodeling, increasing the risk of diastolic dysfunction and heart failure. TAKE HOME MESSAGES: Recurrent coronary spasm may contribute to focal myocardial fibrosis. Left ventricular ejection fraction should be interpreted with end-systolic volume to identify hyperdynamic states.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.